Page values for "Solifenacin"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Solifenacin |
| brand | String | Vesicare |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antimuscarinics|Antimuscarinic (M3-selective)]] • [[:Category:Overactive_bladder_medications|Overactive bladder medication]] |
| mechanism | String | '"`UNIQ--vote-00000DFA-QINU`"' CYP3A4 substrate; QT-interval prolongation has been reported at higher doses. Like other antimuscarinics, contributes to cumulative anticholinergic burden in older adults'"`UNIQ--ref-00000DFB-QINU`"'. |
| uses | String | '"`UNIQ--vote-00000DFC-QINU`"', '"`UNIQ--vote-00000DFD-QINU`"' |
| starting_dose | String | 5 mg PO once daily; titrate to 10 mg after 2 weeks if needed |
| preparations | String | 5, 10 mg tablets |
| fda_max | String | 10 mg/d (5 mg if severe renal or moderate hepatic impairment, or strong CYP3A4 inhibitors) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Symptom improvement within 1-2 weeks |
| duration | String | 24 hours |
| halflife | String | ~45-68 hours'"`UNIQ--ref-00000DFE-QINU`"' |
| bioavailability | String | ~90% (oral)'"`UNIQ--ref-00000DFF-QINU`"' |
| pregnancy | String | Limited data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |